(MENAFN Press) Jaan Tallinn has been named to the Advisory Board for Nanotronics Imaging. Tallinn is widely recognized as one of the foremost innovators in information technology for his work as a founding engineer of Skype and Kazaa
Tallinn is also the co-founder of MetaMed, a personalized medical research company, and a partner at Ambient Sound Investments. In addition, he is one of the founders for the Centre for the Study of Existential Risk at the University of Cambridge and was an advisor and member of the board of Deepmind acquired by Google this year
Nanotronics Imaging, a cutting-edge developer of optical microscopy tools for health and medical care, biotechnology, and life sciences research, recently completed a 7 million Series B financing round from Founders Fund, a San Francisco-based technology investment firm that has backed successful companies including Palantir, MetaMed, SpaceX, Facebook, ZocDoc and The Climate Corporation
Nanotronics Imaging combines state-of-the-art optical microscopy with patented image processing and machine intelligence algorithms to allow for he imaging of a very large area of a specimen with nanoscale resolution
The company's nSpec tool links a computer-controlled microscope and stage with fast image processing techniques to enable high-throughput defect classification and localization for semiconductor substrate and IC chip fabricators
Tallinn said, "Nanotronics Imaging and MetaMed both represent a significant disruptive force in medicine and health: a qualitative improvement in the collection and analysis of health information. The entire field is undergoing a sea change with new ways to collect, monitor, and analyze bio-information becoming available. I'm looking forward to working with Matthew Putman and his team as they continue to develop new applications for the company's optical microscopy technology.
Nanotronics founder Matthew Putman said, "We are thrilled to have Jaan Tallinn join us in developing our vision for transformative technology. His global leadership in health care and technology gives him a unique perspective, and his original thinking is a priceless asset. I am honoured to have him on board.